Ribosomal S6 kinase 4 (RSK4) tumor suppressor gene promoter methylation status in ovarian cancer

Fabian Arechavaleta-Velasco1, Pablo Dominguez-Lopez1, Ernesto Acosta-Jimenez1,2

  • 1Unidad de Investigación Médica en Medicina Reproductiva, UMAE Hospital de Gineco-Obstetricia No. 4 "Luis Castelazo Ayala", Instituto Mexicano del Seguro Social, Av. Rio Magdalena No. 289, Sexto piso. Tizapán, San Angel, CP 01090, Mexico City, Mexico.

PubMed
Abstract

Insights

Ovarian tumors show increased RSK4 promoter methylation, but it doesn't fully explain low RSK4 expression. Reactivating RSK4 expression reduced proliferation in specific ovarian cancer subtypes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Reduced RSK4 mRNA and protein levels are observed in malignant ovarian tumors.
  • A significant inverse correlation exists between advanced ovarian cancer stages and RSK4 mRNA levels.
  • The mechanisms driving RSK4 downregulation in ovarian cancer remain unclear.

Purpose of the Study:

  • To investigate if RSK4 promoter methylation causes reduced RSK4 expression in ovarian cancer.
  • To explore RSK4 expression reactivation and its effects in ovarian cancer cell lines.

Main Methods:

  • Combined bisulfite restriction analysis to assess RSK4 promoter methylation.
  • Decitabine treatment to induce RSK4 reactivation in ovarian cancer cell lines (OVCAR3, SKOV3, TOV-112D, TOV-21G).
  • Western blotting for RSK4 expression, and XTT assay for cell proliferation.

Main Results:

  • Significantly higher RSK4 promoter methylation was found in malignant and benign ovarian tumors compared to normal tissue.
  • RSK4 promoter methylation did not correlate with age, histological subtype, or cancer stage.
  • Decitabine treatment reactivated RSK4 expression in all tested cell lines, but reduced proliferation only in TOV-112D cells.

Conclusions:

  • RSK4 promoter methylation is increased in ovarian tumors but is unlikely the primary regulator of RSK4 expression in ovarian cancer.
  • RSK4 reactivation demonstrated a selective inhibitory effect on cell proliferation, particularly in the endometrioid histological subtype.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.9K